Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 09, 2017 06:00 ET | Source: Quotient Limited

Quotient Limited to Participate in the Jefferies 2017 London Healthcare Conference

JERSEY, Channel Islands, Nov. 09, 2017 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that the Company's Chairman and Chief Executive...
October 30, 2017 16:05 ET | Source: Quotient Limited

Quotient Limited Reports Second Quarter Fiscal 2018 Financial Results

MosaiQ project de-risked, Verification and Validation (“V&V”) “head-to-head” studies confirm targeted concordance levels for all blood grouping assaysEuropean field trials planned to commence...
October 25, 2017 08:00 ET | Source: Quotient Limited

Quotient Reports Positive Concordance Data from MosaiQ Verification and Validation Studies for Blood Grouping and Announces Financing

Verification & Validation (“V&V”) “head-to-head” studies confirm targeted concordance levels for all blood grouping assaysOverall concordance for blood grouping – 99.8%, demonstrating the...
October 25, 2017 08:00 ET | Source: Quotient Limited

Quotient Limited Announces $40 Million Private Placement and the Issue of Warrants to Raise up to an Additional $49 Million

JERSEY, Channel Islands, Oct. 25, 2017 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that it has entered into agreements to issue to...
October 17, 2017 08:00 ET | Source: Quotient Limited

Quotient Limited to Report Fiscal Second Quarter 2018 Financial Results and Host Conference Call

JERSEY, Channel Islands, Oct. 17, 2017 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that financial results for its fiscal second...
September 13, 2017 08:00 ET | Source: Quotient Limited

Quotient Limited to Participate in the Cantor Fitzgerald 2017 Global Healthcare Conference

JERSEY, Channel Islands, Sept. 13, 2017 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that the Company's Chairman and Chief Executive...
September 12, 2017 08:00 ET | Source: Quotient Limited

Quotient Limited Reports Results From Latest MosaiQ Performance Evaluation Studies Prior to Commencing Verification and Validation Studies

Performance evaluation studies confirm required concordance levels for all assaysVerification and validation studies to commence shortly European field trials still expected to be completed in CY17 ...
August 30, 2017 08:00 ET | Source: Quotient Limited

Quotient Limited to Participate in the Morgan Stanley 15th Annual Global Healthcare Conference

JERSEY, Channel Islands, Aug. 30, 2017 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that the Company’s Chairman and Chief Executive...
August 07, 2017 16:05 ET | Source: Quotient Limited

Quotient Limited Reports Results From Ongoing MosaiQ Performance Evaluation Studies and First Quarter Fiscal 2018 Financial Results

Latest performance evaluation studies confirm substantial concordance with predicate technologies for blood grouping and initial disease screening applicationsEuropean field trials expected to be...
July 21, 2017 08:00 ET | Source: Quotient Limited

Quotient Limited to Report Continued Progress on the Commercial Scale-Up of MosaiQ™ and Fiscal First Quarter 2018 Financial Results and Host Conference Call

JERSEY, Channel Islands, July 21, 2017 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that an update on the results of internal...